Skip to main content
logo
Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
10.00
-0.07 (-0.70%)
Mar 20, 2026, 4:00 PM EDT - Market closed

Medifast Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
385.79602.461,0721,5991,526
Revenue Growth (YoY)
-35.97%-43.80%-32.94%4.75%63.24%
Cost of Revenue
110.6157.84296.2458.16398.49
Gross Profit
275.19444.62775.851,1401,128
Selling, General & Admin
289.4441.75649.45955.61911.36
Total Operating Expenses
289.4441.75649.45955.61911.36
Operating Income
-14.212.88126.4184.81216.24
Interest Income
5.524.82.49-0.7-0.23
Other Non-Operating Income (Expense)
3.06-3.9-0.10.050.12
Total Non-Operating Income (Expense)
8.570.912.4-0.66-0.11
Pretax Income
-5.643.79128.8184.06216.13
Provision for Income Taxes
13.031.729.3840.4952.1
Net Income
-18.672.0999.42143.57164.03
Net Income to Common
-18.672.0999.42143.57164.03
Net Income Growth
--97.90%-30.75%-12.47%59.47%
Shares Outstanding (Basic)
1111111112
Shares Outstanding (Diluted)
1111111112
Shares Change (YoY)
0.16%0.39%-3.15%-4.55%-0.31%
EPS (Basic)
-1.700.199.1312.8214.01
EPS (Diluted)
-1.700.199.1012.7313.89
EPS Growth
--97.91%-28.52%-8.35%60.02%
Free Cash Flow
1.2517.02141.17177.8960.34
Free Cash Flow Growth
-92.66%-87.94%-20.64%194.83%-56.69%
Free Cash Flow Per Share
0.111.5512.9315.785.11
Dividends Per Share
--4.9506.5605.680
Dividend Growth
---24.54%15.49%25.66%
Gross Margin
71.33%73.80%72.37%71.34%73.89%
Operating Margin
-3.68%0.48%11.79%11.56%14.17%
Profit Margin
-4.84%0.35%9.27%8.98%10.75%
FCF Margin
0.32%2.83%13.17%11.13%3.95%
EBITDA
0.0315.59139.51195.79223.05
EBITDA Margin
0.01%2.59%13.01%12.25%14.62%
EBIT
-14.212.88126.4184.81216.24
EBIT Margin
-3.68%0.48%11.79%11.56%14.17%
Effective Tax Rate
-231.12%44.78%22.81%22.00%24.11%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q